HNTX-III Alleviates Inflammatory and Neuropathic Pain in Animal Models

  • Yu Liu
  • Zhisheng Liu
  • Qing Wang
  • Zhen Wang
  • Yuxia Zhang
Article

Abstract

Voltage-gated sodium channel plays a critical role in pain sensation and has been considered as a potential target for the development of analgesic drug. Hainantoxin-III(HNTX-III) is a selective inhibitor of neuronal tetrodotoxin-sensitive voltage-gated sodium channels with similar selectivity for Nav1.7, 1.2 and 1.3 but not for Nav1.4 and Nav1.5 from the venom of the spider O. hainana. The aim of the present study is to investigate the analgesic effect of HNTX-III on inflammatory and neuropathic pain models. In the complete Freund’s adjuvant (CFA) model and formalin model of inflammatory pain, HNTX-III produced reversal of hyperalgesia comparable with morphine, and in the spared nerve injury model of pain, HNTX-III inhibited allodynia compared with mexiletine. HNTX-III was also evaluated in a motor coordination assay to assess its propensity for central nervous system side effects, indicating it did not induce impairment of motor coordination. Our findings revealed that HNTX-III significantly alleviated chronic neuropathic pain and acute inflammatory pain and provided a potential template for analgesic drug design in future.

Keywords

HNTX-III Tetrodotoxin-sensitive sodium channel inhibitor Voltage-gated sodium channel Analgesic Inflammatory pain Neuropathic pain 

Notes

Acknowledgements

This work was financially supported by the National Science Foundation of China (No. 31571277), the Natural Science Foundation of Hunan Province, China (No. 2018JJ2150).

Author Contributions

Conceived and designed the experiments: YL, YZ. Performed the experiments: YL, ZL, QW. Contributed the regents/materials/analysis tools: YZ, ZW. Wrote the paper: YL, YZ.

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Billen B, Bosmans F, Tytgat J (2008) Animal peptides targeting voltage-activated sodium channels. Curr Pharm Des 14:2492–2502CrossRefPubMedGoogle Scholar
  2. Black JA, Liu S, Tanaka M, Cummins TR, Waxman SG (2004) Changes in the expression of tetrodotoxin-sensitive sodium channels within dorsal root ganglia neurons in inflammatory pain. Pain 108:237–247CrossRefPubMedGoogle Scholar
  3. Bosmans F, Swartz KJ (2010) Targeting voltage sensors in sodium channels with spider toxins. Trends Pharmacol Sci 31:175–182CrossRefPubMedPubMedCentralGoogle Scholar
  4. Catterall WA (2012) Voltage-gated sodium channel at 60: structure, function and pathaphysiology. J Physiol 590:2577–2589CrossRefPubMedPubMedCentralGoogle Scholar
  5. Cestele S, Catterall WA (2000) Molecular mechanisms of neurotoxin action on voltage-gated sodium channels. Biochimie (Paris) 82:883–892CrossRefGoogle Scholar
  6. Chen JQ, Zhang YQ, Dai J, Luo ZM, Liang SP (2005) Antinociceptive effects of intrathecally administered huwentoxin-I, a selective N-type calcium channel blocker, in the formalin test in conscious rats. Toxicon 45:15–20CrossRefPubMedGoogle Scholar
  7. Chen HP, Zhou W, Kang LM, Yan H, Zhang L, Xu BH, Cai WH (2014) Intrathecal miR-96 inhibits Nav1.3 expression and alleviates neuropathic pain in rat following chronic construction injury. Neurochem Res 39(1):76–83CrossRefPubMedGoogle Scholar
  8. Cox JJ, Reimann F, Nicholas AK, Thornton G, Roberts E, Springell K, Karbani G, Jafri H, Mannan J (2006) An SCN9A channelopathy causes congenital inability to experience pain. Nature 444:894–898CrossRefPubMedGoogle Scholar
  9. Cummins TR, Howe JR, Waxman SG (1998) Slow closed-state inactivation: a novel mechanism underlying ramp currents in cells expressing the hNE/PN1 sodium channel. J Neurosci 18:9607–9619CrossRefPubMedGoogle Scholar
  10. Decosterd I, Woolf CJ (2000) Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87:149–158CrossRefPubMedGoogle Scholar
  11. Dennis SG, Melzack R (1977) Pain-signalling systems in the dorsal and ventral spinal cord. Pain 4:97–132CrossRefPubMedGoogle Scholar
  12. Dib-Hajj SD, Cummins TR, Black JA, Waxman SG (2007) From genes to pain: Na v 1.7 and human pain disorders. Trends Neurosci 30:555–563CrossRefPubMedGoogle Scholar
  13. Dib-Hajj SD, Black JA, Waxman SG (2009) Voltage-gated sodium channels: therapeutic targets for pain. Pain Med 10:1260–1269CrossRefPubMedGoogle Scholar
  14. Dib-Hajj SD, Cummins TR, Black JA, Waxman SG (2010) Sodium channels in normal and pathological pain. Annu Rev Neurosci 33:325–347CrossRefPubMedGoogle Scholar
  15. Drenth JP, Waxman SG (2007) Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders. J Clin Invest 117:3603–3609CrossRefPubMedPubMedCentralGoogle Scholar
  16. Ferrira SH, Vane SR (2005) New aspects on the model of action of nonsteroid anti-inflammatory drugs. Annu Rev Pharmacol 98:267–273Google Scholar
  17. Fertleman CR, Baker MD, Parker KA, Moffatt S, Elmslie FV, Abrahanmsen B, Ostman J, Kluqbauer N, Wood JN (2006) SCN9A mutation in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 52:767–774CrossRefPubMedGoogle Scholar
  18. Fischer TZ, Waxman SG (2010) Familial pain syndromes from mutaions of the NaV1.7 sodium channel. Ann N Y Acad Sci 1184:196–207CrossRefPubMedGoogle Scholar
  19. Gold MS, Weinreich D, Kim CS, Wang R, Treanor J, Porreca F, Lai J (2003) Redistribution of Na(V)1.8 in uninjured axons enables neuropathic pain. J Neurosci 23:158–166CrossRefPubMedGoogle Scholar
  20. Goldberg YP, Macfarlane J, Macdonald ML, Thompson J, Dube MP, Mattice M, Fraser R, Young C (2007) Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genet 71:311–319CrossRefPubMedGoogle Scholar
  21. Gould HJ, England JD, Soignier RD, Nolan P, Minor LD, Liu ZP, Levinson SR, Paul D (2004) Ibuprofen blocks changes in Na v 1.7 and 1.8 sodium channels associated with complete Freund’s adjuvant-induced inflammation in rat. J Pain 5:270–280CrossRefPubMedGoogle Scholar
  22. Hong Y, Abbott FV (1995) Peripheral opioid modulation of pain and inflammation in the formalin test. Eur J Pharmacol 277:21–28CrossRefPubMedGoogle Scholar
  23. Jarvis MS, Honore P, Shieh CC, Chapman M, Joshi S, Zhang XF, Kort M, Carroll W, Marron B (2007) A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc Natl Acad Sci USA 104:8520–8525CrossRefPubMedPubMedCentralGoogle Scholar
  24. Lai J, Gold MS, Kim CS, Bian D, Ossipov MH, Hunter JC, Porreca F (2002) Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel. NaV18 Pain 95:143–152CrossRefPubMedGoogle Scholar
  25. Lee CH, Ruben PC (2008) Interaction between voltage-gated sodium channels and the neurotoxin, tetrodoxin. Channels (Austin) 2:407–412CrossRefGoogle Scholar
  26. Liu Y, Li D, Wu Z, Li J, Nie DS, Xiang Y, Liu ZH (2012) A positively charged surface patch is important for hainantoxin-IV binding to voltage-gated sodium channels. J Pepti Sci 10:643–649CrossRefGoogle Scholar
  27. Liu Y, Wu Z, Xun XH, Nie DS, Xiang Y (2013a) Solid-phase synthesis of the hainantoxin-III and its antinociception analysis in the acid-induced writhing responses of mice. Asian J chem 6:3259–3262Google Scholar
  28. Liu ZH, Cai TF, Zhu Q, Deng MC, Li J, Zhou X, Zhang F, Li D, Li J (2013b) Structure and function of hainantoxin-III, a selective antagonist of neuronal tetrodotoxin-sensitive voltage-gated sodium channels isolated from the Chinese bird spider Ornithoctonus hainana. J Biol Chem 288:20392–20403CrossRefPubMedPubMedCentralGoogle Scholar
  29. Liu Y, Tang JG, Zhang YX, Xun XH, Tang DF, Peng DZ, Yi JM, Liu ZH, Shi XL (2014) Synthesis and analgesic effects of µ-TRTX-Hhn1b on models of inflammatory and neuropathic pain. Toxins 6:2363–2378CrossRefPubMedPubMedCentralGoogle Scholar
  30. McGowan E, Hoyt SB, Li X, Lyous KA, Abbbadie C (2009) A Peripherally acting Na(v)1.7 sodium channel bblocker reverses hyperalgesia and allodynia on rat models of inflammatory and neuropathic pain. Anesth Analg 109:951–958CrossRefPubMedGoogle Scholar
  31. Nassar MA, Stirling LC, Forlani G, Baker MD, Matthews EA, Dickenson AH, Wood JN (2004) Nociceptor-specific gene deletion reveals a major role for Nav1.7(PN1) in acute and inflammatory pain. Proc Natl Acad Sci USA 101:12706–12711CrossRefPubMedPubMedCentralGoogle Scholar
  32. Nassar MA, Levato A, Stirling LC, Wood JN (2005) Neuropathic pain develops normally in mice lacking both Na(v)1.7 and Na(v)1.8. Mol Pain 24:1–9Google Scholar
  33. Nilsen KB, Nicholas AK, Woods CG, Mellgren SI, Nebuchennykh M, Aasly J (2009) Two novel SCN9A mutations causing insensitivity to pain. Pain 143:155–158CrossRefPubMedGoogle Scholar
  34. Osteen JD, Herzig V, Gilchrist J, Emrick JJ, Zhang C, Wang X, Castro J, Grundy L, Rychkov GY (2016) Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain. Nature 06;534(7608):494–499CrossRefGoogle Scholar
  35. Perianayagam JB, Sharma SK, Joseph A, Christina AJ (2004) Evaluation of antipyretic and analgesic activity of Emblica officinalis Gaertn. J Ethnopharmacol 95:83–85CrossRefPubMedGoogle Scholar
  36. Rustay NR, Wahlsten D, Crabbe JC (2003) Influence of task parameters on rotarod performance and selectivity and sensitivity to ethanol in mice. Behav Brain Res 141:237–249CrossRefPubMedGoogle Scholar
  37. Wang W, Gu J, Li YQ, Tao YX (2011) Are voltage-gated sodium channels on the dorsal root ganglion involved in the development of neuropathic pain? Mol Pain 7:16–24PubMedPubMedCentralGoogle Scholar
  38. Xiao YC, Liang SP (2003) Inhibition of neuronal tetrodotoxin-sensitive Na + chanels by two spider toxins: hainantoxin-III and hainantoxin-IV. Eur J Pharmacol 477:1–7CrossRefPubMedGoogle Scholar
  39. Yu FH, Catterall WA (2003) Overview of the voltage-gated sodium channel family. Genome Biol 4:207–214CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature B.V. 2018

Authors and Affiliations

  • Yu Liu
    • 1
  • Zhisheng Liu
    • 1
  • Qing Wang
    • 1
  • Zhen Wang
    • 1
  • Yuxia Zhang
    • 1
  1. 1.College of Chemistry and Chemical EngineeringHunan Institute of Science and TechnologyYueyangChina

Personalised recommendations